Is an electronic signature legally valid?

Yes. Electronic signatures meet the ESIGN Act and UETA standards when intent, consent, attribution, and retention are present; include clear recordkeeping and a reproducible audit trail.

Can PHI be included and e-signed?

Yes, but a Business Associate Agreement (BAA) is required for PHI processing; the signing platform must support HIPAA workflows and a BAA to limit regulatory exposure.

When is notarization required?

Notarization depends on state law and document type. If a deed, affidavit, or state rule requires notarization, obtain it; remote notarization may be accepted where permitted.

Who may sign for a seller entity?

An authorized officer or agent with documented signing authority must sign; corporate resolutions or LLC member consents are advisable to evidence authority.

How do we amend the agreement after signing?

Use a written amendment signed by all parties specifying changes and effective dates; oral modifications are risky and may be unenforceable.

How should signed copies be stored?

Store an immutable, timestamped copy in secure records with encrypted backups and access controls; retain per legal and HIPAA retention schedules.

Electronic Signature
Templates
Healthcare
Healthcare Seller Representation Agreement

Healthcare Seller Representation Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE SELLER REPRESENTATION AGREEMENT

This Healthcare Seller Representation Agreement (the Agreement) is made effective as of by and between Seller Name: (Seller) and Representative / Broker: .

1. Parties and Contact Information

Seller: Legal Entity Entity Type

LLC Corporation Sole Proprietor Other:

Seller Address Primary Contact Representative / Broker

2. Recitals

WHEREAS Seller owns or controls the business identified as:

WHEREAS Seller desires to engage Representative to market the business, solicit offers, and assist in negotiating the sale on the terms set forth in this Agreement; and Representative is willing to provide such services on the terms herein.

3. Appointment; Scope of Authority

Seller hereby appoints Representative as its exclusive (unless otherwise initialed below) agent to market and solicit purchase proposals for the sale of the business and related assets described above. Exclusive appointment:

Representative is authorized to: solicit and evaluate offers; present prospective purchasers; coordinate due diligence; and engage in negotiations on Seller’s behalf subject to Seller's prior written approval of any definitive agreement. Representative shall not execute or deliver any agreement on Seller’s behalf except as expressly authorized in writing.

4. Term; Termination

The initial term of this Agreement shall commence on the Effective Date above and shall continue for a period of months unless earlier terminated pursuant to this Agreement. Seller may terminate for material breach following a written cure period of days.

5. Compensation; Expenses

Seller shall pay Representative a commission equal to % of the gross purchase price, or a flat fee of if specified by mutual agreement. Commission shall be due and payable at closing or upon execution of a binding sale agreement as defined below.

For purposes of this Agreement, "gross purchase price" includes cash, assumption of liabilities, seller notes, earnouts, and other consideration (excluding escrowed or contingent amounts until collected). If a portion of the purchase price is contingent, Representative’s commission on contingent consideration shall be payable when and to the extent Seller actually receives such amounts.

Seller shall reimburse documented, pre-approved out-of-pocket expenses incurred by Representative in marketing the business, including travel and reasonable data-room costs, within thirty (30) days of invoicing.

6. Confidentiality; Protected Health Information

Representative shall hold all Confidential Information in confidence and shall not disclose such information except to prospective purchasers under written non-disclosure obligations. Confidential Information includes financial records, patient lists, and other non-public business information. Representative shall use commercially reasonable measures to protect Confidential Information.

To the extent disclosure or access to protected health information (PHI) is necessary for prospective purchaser due diligence, Seller authorizes Representative to disclose PHI only after Seller obtains any required patient authorizations and to the extent permitted by applicable law. Seller authorizes disclosure through:

PHI authorization expiration date:

7. Seller Representations and Warranties

Seller represents and warrants (each a representation) to Representative that, as of the Effective Date and at closing: (a) Seller has full power and authority to enter into this Agreement and to consummate the sale; (b) financial statements provided to Representative are true and correct in all material respects; (c) Seller is in compliance with applicable healthcare laws and reimbursement program requirements; (d) there are no undisclosed material liabilities or proceedings affecting the business; and (e) Seller shall maintain licenses required to operate through closing.

Seller Disclosures (material exceptions to warranties)

8. Cooperation; Access to Records; Due Diligence

Seller shall provide Representative and prospective purchasers reasonable access to personnel, facilities, books and records for due diligence purposes, subject to confidentiality protections. Seller shall coordinate any required patient authorization forms and shall not unreasonably withhold approval for prospective purchaser access consistent with law.

Due Diligence Coordinator

9. Marketing; Use of Materials

Representative may prepare marketing materials and confidential offering memoranda describing the business. Representative will obtain Seller’s prior written approval of materials that disclose Seller-identifying information or key financial metrics. Representative may use anonymized summaries for preliminary outreach.

Marketing Restrictions / Special Instructions

10. Offers and Acceptance

All offers shall be delivered to the Seller’s representative named above. Seller retains sole authority to accept or reject any offer. Representative shall promptly deliver to Seller all material communications from prospective purchasers. Seller designates the following recipient for receipt of offers:

11. Indemnification; Limitation of Liability

Each party shall indemnify, defend and hold harmless the other from and against losses arising from breaches of representations, willful misconduct, or gross negligence. Representative’s liability for any claim arising under this Agreement shall be limited to direct damages and shall not include consequential, incidental or punitive damages except for willful misconduct or fraudulent acts.

12. Governing Law; Venue

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflicts of law principles. Venue for any dispute shall be in the state or federal courts located in the county specified by Seller:

13. Notices

Notices under this Agreement shall be sent to the addresses set forth below or to such other address as a party may designate in writing.

Seller Notice Address Representative Notice Address

14. Miscellaneous

This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and supersedes all prior agreements. No amendment shall be effective unless in writing and signed by both parties. This Agreement may be executed in counterparts and by electronic signature, each of which shall be deemed an original.

Additional Terms / Agreed Amendments

Seller:

By:

Date:

Representative:

By:

Date:

What the Healthcare Seller Representation Agreement Is

A Healthcare Seller Representation Agreement is a contractual document used when selling health-related assets, practices, or service lines. It records the seller's factual statements, representations, and warranties about regulatory compliance, licensing, patient records handling, billing practices, and ownership of assets. Buyers rely on these statements to assess risk and trigger indemnities or price adjustments. The agreement typically includes schedules, disclosures, survival periods for representations, closing conditions, and remedies for breaches; in healthcare transactions it must address HIPAA and privacy obligations, third-party payor arrangements, and any required consents.

Why this Agreement Matters for Healthcare Transactions

Clear seller representations allocate risk, protect buyer expectations, and define remedies for breaches. For healthcare deals, the agreement helps document HIPAA compliance, payer relationships, and licensing status, reducing regulatory and financial exposure during due diligence and post-closing adjustments.

Who Typically Prepares and Signs This Agreement

Several parties converge to prepare, review, and sign a Healthcare Seller Representation Agreement depending on deal size and structure.

Seller principals and practice owners — Provide factual disclosures, sign representations, and approve attached schedules.
Buyers and acquiring entities — Rely on representations for valuation, due diligence, and indemnity claims.
Advisors and counsel — Attorneys, brokers, and accountants draft, negotiate, and validate regulatory and tax information.

Roles vary by transaction complexity; authorized signatory and counsel involvement reduces post-closing disputes.

Core Sections You Should Expect in the Agreement

A professional Healthcare Seller Representation Agreement groups the deal into distinct sections that allocate risk, list exceptions, and specify closing mechanics; each section should be clear, measurable, and tied to supporting schedules or exhibits.

Representations

Detailed statements about corporate authority, licensure, regulatory compliance, patient record integrity, and billing accuracy that the seller affirms to the buyer.

Disclosures

Schedules listing exceptions to representations such as open investigations, payer audits, leases, or pending litigation that provide context for risk allocation.

Indemnification

Mechanics for losses arising from breaches, including caps, baskets, survival periods, and procedures for notice and defense of claims.

Closing Conditions

Conditions precedent to closing such as regulatory approvals, consent from payors, assignment of contracts, and delivery of certified documents.

Survival

Timeframe during which representations remain actionable post-closing and which representations expire immediately versus those that survive longer.

Privacy & HIPAA

Specific clauses addressing PHI handling, required business associate agreements, and obligations to remediate breaches or notify affected parties.

Essential Data and Security Elements to Record

Encryption: AES-256 at rest

In-transit Security: TLS 1.2 / 1.3

Access Controls: Role-based access

BAA Requirement: Execute BAA for PHI

Audit Trail: Timestamped signing log

Signature Evidence: IP, timestamp, and ID

Step-by-Step: How to Complete and Execute the Agreement

Follow this sequence from drafting through execution to ensure a clean closing and enforceable seller representations.

01

Draft: Populate clauses, attach schedules, and specify survival periods.
02

Review: Have counsel and advisors verify regulatory and tax disclosures.
03

Negotiate: Exchange markups, resolve exceptions, and agree on indemnity limits.
04

Execute: Obtain authorized signatures, notarizations, and required consents.

How to Configure a Digital Signing Workflow

Set up a repeatable online workflow that secures signatures, captures audit data, and routes documents for required approvals.

Field	Configuration
Authentication	Email link, SMS code, or advanced KBA
Conditional Fields	Show or hide schedules based on answers
Audit Trail	Enable timestamp, IP, and signer data
Template Library	Save base agreement and reuse with placeholders

Technical Considerations for eSigning and eSubmission

Ensure the signing platform supports required security, audit, and industry compliance features before eSubmission.

Integrations: Salesforce, NetSuite, Google Workspace
File Formats: PDF, DOCX, and form-fillable PDFs
Authentication Options: Email, SMS, or advanced ID checks

Confirm platform BAAs for PHI and that signed records are exportable to your records management system in immutable format.

Typical Online Execution Flow

A standard digital signing flow reduces turnaround time while preserving evidence of intent, access, and consent for each signer.

Upload Document: Sender uploads final agreement and attachments.
Place Fields: Add signature, initial, and date placeholders.
Route to Signers: Assign signing order or use parallel signing.
Complete: Signers authenticate, sign, and receive copies.

Common Preparation Mistakes to Avoid

Incomplete schedules: failing to attach detailed asset lists or exception schedules that the buyer expects increases dispute risk and may delay closing.
Name mismatches: entering legal entity names differently than formation documents can create enforceability problems and require corrective amendments.
Missing HIPAA consents: failing to include required business associate agreements or patient authorization language can trigger regulatory penalties.
Unclear signature authority: allowing individuals to sign without documented authority leads to later challenges of validity and potential rescission.

Top Risks and Consequences of Errors

Tax Penalties: Backup withholding risk

Contract Rescission: Buyer may seek rescission remedy

Regulatory Fines: HIPAA enforcement exposure

Indemnity Exposure: Large post-closing claims

Closing Delays: Missing consents postpone closing

Reputational Harm: Disputes harm future transactions

eSignature Provider Comparison for Executing This Agreement

Comparing core plan features can help choose a provider that supports HIPAA workflows, audit trails, and bulk send for high-volume transactions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card	Free trial available	Free trial available	Free plan limited	Free plan limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions About Execution and Validity

Answers to frequent questions about enforceability, HIPAA considerations, notarization, signer authority, amendments, and storage for Healthcare Seller Representation Agreements.

Need help? Contact support

Is an electronic signature legally valid?
Yes. Electronic signatures meet the ESIGN Act and UETA standards when intent, consent, attribution, and retention are present; include clear recordkeeping and a reproducible audit trail.
Can PHI be included and e-signed?
Yes, but a Business Associate Agreement (BAA) is required for PHI processing; the signing platform must support HIPAA workflows and a BAA to limit regulatory exposure.
When is notarization required?
Notarization depends on state law and document type. If a deed, affidavit, or state rule requires notarization, obtain it; remote notarization may be accepted where permitted.
Who may sign for a seller entity?
An authorized officer or agent with documented signing authority must sign; corporate resolutions or LLC member consents are advisable to evidence authority.
How do we amend the agreement after signing?
Use a written amendment signed by all parties specifying changes and effective dates; oral modifications are risky and may be unenforceable.
How should signed copies be stored?
Store an immutable, timestamped copy in secure records with encrypted backups and access controls; retain per legal and HIPAA retention schedules.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now